12 States Seek To Enjoin FDA’s REMS Restriction On Mifepristone Abortion Drug

(February 28, 2023, 1:08 PM EST) -- SEATTLE — Twelve state attorneys general have filed a complaint and an injunction motion against the Food and Drug Administration seeking a court order for the agency to remove its newly announced Risk Evaluation and Mitigation Strategy (REMS) restriction on mifepristone, one of the two drugs prescribed for medication abortions, saying the designation is unnecessary due to the drug’s established safety and efficacy....

Related Sections